Left atrial (LA) volume and function are robust markers of cardiovascular risks and adverse
cardiac outcomes. With advances in imaging technology, including tissue Doppler, strain …

Left atrial (LA) volume has recently been identified as a potential biomarker for cardiac and
cerebrovascular disease. However, evidence regarding the prognostic implications of LA …

Since left atrial (LA) enlargement per se was found to be associated with mortality and with
cardiovascular events 1 20 years ago, advances in imaging technology have given …

Highlights•The LA is emerging as a biomarker for evaluation of diastolic dysfunction, AF, and
HFpEF.•LA size, although routinely evaluated by 2DE, may be more accurately evaluated by …

Left atrial (LA) enlargement has been proposed as a barometer of diastolic burden and a
predictor of common cardiovascular outcomes such as atrial fibrillation, stroke, congestive …

Echocardiographically determined left atrial (LA) size has been shown to be a significant
predictor of cardiovascular (CV) outcomes. We review the physiology and …

The interest in the left atrium (LA) has resurged over the recent years. In the early 1980s,
multiple studies were conducted to determine the normal values of LA size. Over the past …

In patients without valve disease, an increased left atrial size represents the integration of LV
diastolic performance over time (long-term biomarker of diastolic dysfunction), regardless of …

The left atrium (LA) is often regarded as a biomarker of cardiovascular risk. It serves several
important functions: it modulates left ventricular filling and cardiovascular performance by …

OBJECTIVES: Left atrial (LA) volume (LAV) is a prognostically important biomarker for
diastolic dysfunction, but its reproducibility on repeated testing is not well defined. LA …